ADXN Stock Analysis: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$4.05
-0.89 (-18.02%)
▼
5d:
-30.17%
30d:
-28.95%
90d:
-34.04%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Oct 05, 2026
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADXN is down 30.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADXN is down 30.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $4.05, which is considered oversold relative to its 30-day fair value range of $4.91 to $6.02.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $3.76, while resistance sits at $6.21. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: ADXN scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+640.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADXN is in a downtrend. Immediate support is located at $3.76, while resistance sits at $6.21. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: ADXN scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+640.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.91 -
$6.02
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-18.0%)
- BULLISH: Trading 640.7% below Wall St target ($30.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.91 -
$6.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.76
Resistance Level
$6.21
Current Trend
Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Wall Street Target
$30.00
(+640.7%)
Revenue Growth (YoY)
-89.2%
Share & Embed Analysis
Last updated: August 24, 2026 8:53 PM ET
Data refreshes hourly during market hours. Next update: 9:53 PM
Data refreshes hourly during market hours. Next update: 9:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 48 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 37 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 40 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 62 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 33 SELL |
